Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
On December 20, 2021, Amgen announced the FDA approval of Otezla (apremilast), for the treatment of adult patients with plaque psoriasis who are candidates for phototherapy or systemic therapy.
